185.4 185.4 186.1 183.0 184.9 184.9 4 Profit and Loss Transaction For the three-month period ended September 30, CONSOLIDATED Change (BAHT'000) 2018 2017 Amount % Interest income 4,200,604 3,820,103
. Indo-Rama Synthetics Tbk. ซึง่เป็นบคุคลท่ีเก่ียวโยงกนั เหตุผลของการเข้าท ารายการ (Rationale of the transaction) ตามสญัญาคอลออปชัน่ (Call Option Agreement) ระหวา่ง INBV และ PTIRS ฉบบัลงวนัท่ี 30 พฤศจิกายน
million in Q1/2019 whereas there was no such transaction in Q1/2020. And there was an increase in reduction cost of inventory to net realizable value amounting of Baht 1.5 million in Q1/2020 compared to
, consolidated financial statement has net loss of Baht 41 million and net profit of Baht 39 million, respectively. This was resulted from non-core business transaction of the Company, which is accounted for Baht
reversal of such transaction of Baht 0.7 million in Q2/2020. The interest expenses in Q2/2020 was Baht 1.9 million, or 44.19% decreased from Baht 3.3 million of Q2/2019. This was due to the downward trend of
, the Company would like to report the progress of this transaction that during Q4/2019 Wuttisak Clinic sent the notification letter to TPN requesting the debt payment. In addition, Wuttisak Clinic
Statement year ended March 31, 2020 Return on Assets and Return on Equity of 1Q’20 deteriorated yoy. because of high profit of base year which was driven by both the hospital business and extra transaction of
of the previous year, mostly from revenue from Trading (Big Lot – non regular transaction) decreased Baht 852.55 million. 2. Gross profit was Baht 55.63 million which decreased Baht 53.55 million or
, with the condition that the seller has to commit and follow the condition stated in the agreement before entering into this transaction. This investment with the total amount of USD 3.9 million or Baht
related transaction. Gross Profit and Gross Profit Margin For the second Quarter 2020, the Company had gross profit by THB 181.02 Million which was increased by THB 110.50 Million or 156.69% and Gross